Aspect Partners
NEO icon

Aspect Partners’s NeoGenomics NEO Stock Holding History

Aspect Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.49K Buy
81
+4
+5% +$66 ﹤0.01% 542
2026
Q2 		$1.12K Buy
+77
New +$743 ﹤0.01% 562

Other funds holding NEO

Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Moody National Bank Trust Division
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Aspect Partners's NEO Position: Q3 2026 in Review

Aspect Partners increased its NeoGenomics (NEO) stake by 5.2% in Q3 2026, buying an estimated $66 and bringing the position to 81 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Aspect Partners first reported a position in NEO in Q2 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Aspect Partners held 81 shares of NeoGenomics worth $1.49K as of Q3 2026.
  • Aspect Partners bought 4 NeoGenomics shares in Q3 2026, an estimated $66.
  • NeoGenomics made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #542 holding.
  • Aspect Partners first reported a position in NeoGenomics in Q2 2026 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.